4.2 Article

Modulation of the transforming growth factor beta 1 by vitamin E in early nephropathy

期刊

MEDICAL PRINCIPLES AND PRACTICE
卷 14, 期 6, 页码 422-429

出版社

KARGER
DOI: 10.1159/000088116

关键词

diabetic nephropathy; vitamin E; lipid peroxidation; TGF-beta 1 mRNA

向作者/读者索取更多资源

Objective: The aim of this study was to investigate the pharmacological activity of an antioxidant, alpha-tocopherol ( vitamin E, VE) in streptozotocin-induced diabetic rats and study its role in modulating the transforming growth factor beta 1 (TGF-beta 1). Methods: Male Sprague-Dawley rats were treated with streptozotocin to induce diabetes. VE and/or insulin ( INS) were administered daily during treatment periods of 3, 5, 7 and 10 days. Plasma glucose and fructosamine were measured in diabetic rats at the end of each treatment period. Samples of plasma, urine and renal cortex were analyzed for changes in protein and lysozyme excretion, reduced glutathione and malondialdehyde formation. TGF-beta 1 was determined by ELISA and expression of TGF-beta 1 mRNA was investigated by RTPCR and Northern blot analysis. Results: Diabetes-induced glycemic stress was suppressed by INS, VE or a combination of INS and VE. Diabetes-induced increases of glucose, protein and lysozyme excretion were markedly depressed after 10-day treatment with INS, VE and the combination of INS and VE. Decreased glutathione content in the renal cortex of diabetic rats recovered towards control values, especially after 10-day treatment. Malondialdehyde content increased in diabetic rats and was reduced towards control value following 7- and 10-day treatments. Treatment of diabetic rats with INS, VE or the combination of INS and VE decreased elevated TGF-beta 1 in plasma, decreased excretion of TGF-beta 1 in urine, and decreased renal cortex TGF-beta 1 mRNA levels. Conclusions: Diabetes-induced overexpression of TGF-beta 1 mRNA was suppressed by VE and INS after 5-, 7- and 10-day treatments. The results obtained with the antioxidant VE suggest that oxidative stress is involved in the development of diabetic nephropathy. Therefore, VE treatment may be effective in early stages of diabetic nephropathy to decrease or prevent pathological complications. Copyright (C) 2005 S. Karger AG, Basel.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据